Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 281
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00617903 | Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea | ||
| NCT01836367 | Ingenol Mebutate 0.015% Gel in the Treatment of Actinic Keratoses (AK) on the Face and Scalp | ||
| NCT00875277 | A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products | ||
| NCT03761537 | Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis - ECZTRA 7 | ||
| NCT00851864 | Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing | ||
| NCT05388760 | Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1) | ||
| NCT02605057 | Dermatopharmacokinetic Trial of LEO 80185 Gel | ||
| NCT00817219 | Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris | ||
| NCT03402828 | Body PSOriasis: Long-term Relapse CONTROL | ||
| NCT02594436 | The Use of Picato® (Ingenol Mebutate) to Treat Actinic Keratosis in Standard Clinical Practice | ||
| NCT01701843 | Cromoglicate in Mastocytosis | ||
| NCT00670241 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris | ||
| NCT02695940 | Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis | ||
| NCT05355818 | Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand Eczema | ||
| NCT01559883 | Study on Thrombosis Therapy in German Cancer Patients | ||
| NCT03898583 | Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. | ||
| NCT01105234 | An Irritation Study With New Calcipotriol Ointment Formulations in Healthy Subjects | ||
| NCT03995550 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese | ||
| NCT00252408 | Danish Osteoporosis Prevention Study | ||
| NCT00689520 | Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis | ||
| NCT00758862 | The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or Impetigo | ||
| NCT05194540 | Efficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA) | ||
| NCT02549352 | Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up | ||
| NCT01025635 | Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea | ||
| NCT02664805 | Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema | ||
| NCT05295732 | The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis | ||
| NCT05098821 | Extrinsic and Intrinsic Factors in Atopic Dermatitis Upon Systemic Immune Modulation | ||
| NCT05958407 | A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy | ||
| NCT02600598 | Biological Effects of LEO 43204 in Actinic Keratosis | ||
| NCT03363854 | Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 | ||
| NCT05682976 | Ophthalmological Adverse Events of Tralokinumab in AD | ||
| NCT06773455 | Tralokinumab for Dupilumab Failures | ||
| NCT00404196 | LEO19123 Cream in the Treatment of Hand Eczema | ||
| NCT07335588 | A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus | ||
| NCT01007383 | LEO 27847 - A Study in Healthy Male Subjects | ||
| NCT03478280 | Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis | ||
| NCT06386107 | Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis | ||
| NCT02260414 | Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer | ||
| NCT03526861 | Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). | ||
| NCT00475605 | A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis | ||
| NCT00216879 | Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis | ||
| NCT02406014 | Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp | ||
| NCT01229098 | Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris | ||
| NCT02132936 | LEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis Vulgaris | ||
| NCT07444801 | Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact | ||
| NCT00216892 | Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris | ||
| NCT01423656 | Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102 | ||
| NCT03336372 | Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients | ||
| NCT02514694 | LEO 32731 - A Phase I Study in Healthy Subjects | ||
| NCT03683719 | Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema |
